It is a pharma private limited company based in Lower Parel, Maharashtra, India, established in 2019.
2019 | Lower Parel, Maharashtra, India | ActiveIntermed Laboratories Private Limited, a active private limited company, was established on 14 October 2019 in Lower Parel, Maharashtra, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24230MH2019PTC331617. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.10 M.
Formerly known as Intermed Laboratories Private Limited, Intermed Pharmaceuticals Private Limited. Employing 53 professional, Its leadership includes Paresh Mehta Kirtilal (Director), Rushabh Paresh Mehta (Director), Riddhi Sahil Javeri (Director). Past directors included Paresh Mehta Kirtilal, Rushabh Paresh Mehta, Sahil Sagar Javeri. It holds ₹38.16 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at A-3, Floor-G, A, Todi Industrial Estate, Sitaram Jadhav Marg, Sun Mill Compound,, Lower Parel, Maharashtra, 400013.
U24230MH2019PTC331617
331617
14 October 2019
₹0.50 M
₹0.10 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Intermed Laboratories Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Paresh Mehta Kirtilal | Director | 10 Aug 2021 | Current |
| Rushabh Paresh Mehta | Director | 24 Aug 2021 | Current |
| Riddhi Sahil Javeri | Director | 14 Oct 2019 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 30 Nov 2021 | Past |
| Pramod Abcsdd | Additional Director | 30 Nov 2021 | Past |
| Pramod Abcsdd | Director | 10 Aug 2021 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Intermed Laboratories Private Limited, for the financial year ended 2024, experienced modest growth in revenue, with a 4.05% increase. The company also saw a substantial fall in profitability, with a 15% decrease in profit. The company's net worth Soared by an impressive increase of 92.93%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2024, Intermed Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹381,562,384.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 26 Jun 2025 | Yes Bank Limited | ₹1.21 Cr | Open |
| 29 Oct 2021 | Yes Bank Limited | ₹36.95 Cr | Open |
Explore comprehensive loan charge details -
Intermed Laboratories has a workforce of 53 employees as of Feb 28, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Intermed Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Intermed Laboratories's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on A charge with Yes Bank Limited amounted to Rs. 12.09 M with Charge ID 101120428 was registered on 26 Jun 2025. was documented.
Progress on A charge with Yes Bank Limited of Rs. 369.47 M registered on 29 Oct 2021 with Charge ID 100500888 was modified on 25 Feb 2025. was documented.
The activity Intermed Laboratories Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
The activity Intermed Laboratories Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was completed.
Progress on A charge with Yes Bank Limited amounted to Rs. 369.47 M with Charge ID 100500888 was registered on 29 Oct 2021. was documented.
The activity Rushabh Paresh Mehta was appointed as a Director was appointed as a Director on 24 Aug 2021 & has been associated with this company since 4 years 4 months . was completed.
The CIN of Intermed Laboratories Private Limited is U24230MH2019PTC331617.
Intermed Laboratories Private Limited is headquartered at A-3, Floor-G, A, Todi Industrial Estate, Sitaram Jadhav Marg, Sun Mill Compound,, Lower Parel, Maharashtra, 400013.
Intermed Laboratories Private Limited was incorporated on 14 October 2019.
The current directors of Intermed Laboratories Private Limited are
The primary industry of Intermed Laboratories Private Limited is Manufacturing.
Intermed Laboratories Private Limited is unlisted.
The authorized capital of Intermed Laboratories Private Limited is ₹0.50 M, and the paid-up capital is ₹0.10 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX